Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 7, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07492498). This is a study registration, not published results. Lead sponsor: Jiangsu Taizhou People's Hospital. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 1356 participants (ESTIMATED). Conditions: Atrial Fibrillation, Heart Failure. Interventions: OTHER: Village-Doctor Led Integrated Care; OTHER: Usual Care. Primary outcome measures: Primary Outcome of Phase 1: Change in Life's Essential 8 Cardiovascular Health Score , Baseline to 12 months; Primary Outcome of Phase 2: Composite Cardiovascular Outcome , Baseline to 36 months; Primary Outcome of Phase 3: New-incident heart-failure diagnosis , Baseline to 48 months; Primary Outcome of Extension Study: Composite cardiovascular outcome , Baseline to 84 months. Brief summary: This cluster randomized study aims to compare village doctor-led integrated care versus usual care to improve cardiovascular health, atrial fibrillation management, self-management adherence, and heart failure prevention among older rural patients with atrial fibrillation in China.The primary outcome at 12 months is the change in Life's Essential 8 cardiovascular health score from baseline (phase 1). The primary outcome at 36 months is a composite cardiovascular endpoint including cardiovascular death, ischemic or hemorrhagic stroke, hospitalization for worsening HF or acute coronary syndrome, and emergency department visits due to AF (phase 2) . The primary outcome at 48 months is new-incident heart-failure diagnosis (phase 3) .An extended observational follow-up, the new-incident heart-failure diagnosis observational follow-up study, will be conducted at Year 7 to evaluate long-term effects.